Literature DB >> 19484351

Impact of a public sensitization campaign on migraine management in France.

Anne Donnet1, Michel Lantéri-Minet, Gilles Géraud, Evelyne Guegan-Massardier, Geneviève Demarquay, Pierric Giraud, Christian Lucas, Dominique Valade.   

Abstract

Migraine is a common and frequently disabling condition. Nevertheless, many migraine sufferers do not consult for migraine, are not medically followed up and self-treat the attacks. "Tour de France of migraine" consisted of free-access conferences held in six large towns in France following a wide public information campaign. This sensitization campaign aimed at providing participants with educational information on migraine disease and on current therapies. Headache sufferers were then invited to respond to two consecutive questionnaires delivered at the end of the conferences and 3 months later to assess the influence of the information delivered on their migraine management. Tour de France of migraine recruited mainly severe migraine sufferers, most of whom had already consulted and were medically followed up. However, migraine management was often suboptimal in these subjects since most of them found their acute treatment of attacks ineffective and only few of them received a prophylactic treatment. Three months after the conferences, more than half of respondents had consulted for headaches. There was a significant improvement in migraine-related disability, as reflected by a significant decrease in mean Headache Impact Test 6-item score, which might have been related to the higher proportion of subjects receiving a prophylactic treatment of migraine. The Tour de France of migraine campaign revealed the difficulty in sensitizing migraine sufferers towards the necessity of being medically followed up. Mainly patients with severe migraine attended the conferences and derived clinical benefit from the educational program. Other strategies should be developed to reach a wider population of migraine sufferers.

Entities:  

Mesh:

Year:  2009        PMID: 19484351      PMCID: PMC3451749          DOI: 10.1007/s10194-009-0128-0

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  16 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  European principles of management of common headache disorders in primary care.

Authors:  T J Steiner; K Paemeleire; R Jensen; D Valade; L Savi; M J A Lainez; H-C Diener; P Martelletti; E G M Couturier
Journal:  J Headache Pain       Date:  2007-10       Impact factor: 7.277

3.  Migraine and probable migraine--results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification.

Authors:  M Lantéri-Minet; D Valade; G Géraud; M H Chautard; C Lucas
Journal:  Cephalalgia       Date:  2005-12       Impact factor: 6.292

4.  Migraine in the United States: epidemiology and patterns of health care use.

Authors:  R B Lipton; A I Scher; K Kolodner; J Liberman; T J Steiner; W F Stewart
Journal:  Neurology       Date:  2002-03-26       Impact factor: 9.910

5.  FRAMIG 2000: medical and therapeutic management of migraine in France.

Authors:  C Lucas; C Chaffaut; M-A Artaz; M Lantéri-Minet
Journal:  Cephalalgia       Date:  2005-04       Impact factor: 6.292

6.  A six-item short-form survey for measuring headache impact: the HIT-6.

Authors:  M Kosinski; M S Bayliss; J B Bjorner; J E Ware; W H Garber; A Batenhorst; R Cady; C G H Dahlöf; A Dowson; S Tepper
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

7.  A self-administered screener for migraine in primary care: The ID Migraine validation study.

Authors:  R B Lipton; D Dodick; R Sadovsky; K Kolodner; J Endicott; J Hettiarachchi; W Harrison
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

8.  French guidelines for the diagnosis and management of migraine in adults and children.

Authors:  Gilles Géraud; Michel Lantéri-Minet; Christian Lucas; Dominique Valade
Journal:  Clin Ther       Date:  2004-08       Impact factor: 3.393

Review 9.  Medication-overuse headache: a worldwide problem.

Authors:  Hans-Christoph Diener; Volker Limmroth
Journal:  Lancet Neurol       Date:  2004-08       Impact factor: 44.182

10.  Intensive community pharmacy intervention had little impact on triptan consumption: a randomized controlled trial.

Authors:  Jens Søndergaard; Annette Foged; Jakob Kragstrup; David Gaist; Lars Freng Gram; Søren Hein Sindrup; Hans Ulrik Schaffalizky de Muckadell; Bente Overgaard Larsen; Hanne Herborg; Morten Andersen
Journal:  Scand J Prim Health Care       Date:  2006-03       Impact factor: 2.581

View more
  2 in total

1.  Long-term effects of a sensitisation campaign on migraine: the Casilino study.

Authors:  B Petolicchio; L Di Clemente; M Altieri; E Vicenzini; G L Lenzi; Vittorio Di Piero
Journal:  J Headache Pain       Date:  2010-04       Impact factor: 7.277

2.  Access to care--an unmet need in headache management?

Authors:  Cristina Tassorelli; Ingemar Farm; Hilkka Kettinen; Elena Ruiz de la Torre; Srdjan Stretenovic; Wendy Thomas; Peter Vriezen; Leo Van Os; Dietmar Krause; Audrey Craven
Journal:  J Headache Pain       Date:  2014-04-17       Impact factor: 7.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.